Search

everythinglearnresearchcommunity

for

Search:↓

Long-term use of a certain medication can worsen erectile function in aged rats by damaging penile muscle cells.

Regulatory challenges make developing combination therapies in urology difficult and costly.

9-cis-retinoic acid showed some effectiveness in treating AIDS-related Kaposi sarcoma but had significant side effects at higher doses.

Kir6.1 mutations in Cantú syndrome increase channel sensitivity and hyperpolarization, while SUR2B mutations do not.

Men with better urinary symptoms have a lower risk of death.

Compound 4 is a promising treatment for hair loss with low toxicity.

Sorafenib may cause hair loss in a way similar to alopecia areata.

Minoxidil sulfate and pinacidil may promote hair growth through increased blood flow, not by activating potassium channels.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Taking 5-alpha reductase inhibitors might be linked to breast cancer in men.

Baricitinib helped most teenagers with severe hair loss regrow hair and had mild side effects.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

Spironolactone may cause increased brain pressure in some patients.

cp-asiAR may effectively treat hair loss by targeting androgen receptors.

Fludalanine failed as an effective oral antibiotic despite efforts.

JAK inhibitors can help treat alopecia areata but have risks and high costs.

Baricitinib improves alopecia areata and may help psoriasis but might not be ideal for psoriatic arthritis.

The inhibitor affects androgen metabolism but not ovarian function.

Low-dose oral minoxidil is safe for the heart in the short term for hair loss patients.

A method was found to accurately measure spironolactone and canrenone in blood samples using liquid chromatography-mass spectrometry.

BBR-SA nanomedicine is a safe and effective treatment for breast cancer.

Baricitinib maintains significant hair regrowth in severe alopecia areata over three years.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

Vitamin D and estrogen may help protect heart and kidney health, and maintaining sufficient vitamin D levels could be especially beneficial for African Americans, postmenopausal women, and people with chronic kidney disease.

Both dutasteride and finasteride improve urinary symptoms, but dutasteride may be better at reducing the risk of prostate surgery and sudden inability to urinate.

Oral minoxidil users, especially for hypertension, may risk heart issues, and better monitoring guidelines are needed for alopecia patients.

AH-001 could be a safer and more effective treatment for hair loss.